The persistence of tadalafil monotherapy and the reasons for withdrawal from treatment of treatment-naive patients with benign prostatic hyperplasia in the real-world clinical setting
Not Applicable
- Conditions
- Benign prostatic hyperplasia
- Registration Number
- JPRN-UMIN000032766
- Lead Sponsor
- Hokkaido Prefectural Esashi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Male
- Target Recruitment
- 113
Inclusion Criteria
Not provided
Exclusion Criteria
urinary tract infection, acute urinary retention, prostate cancer, neurogenic bladder, the use of an alpha-1 adrenoceptor antagonist or anti-androgen, and a history of prostatic surgery
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The persistence of tadalafil monotherapy and the reasons for withdrawal from treatment
- Secondary Outcome Measures
Name Time Method